• Bausch Health Companies Inc BHC.TO reported quarterly adjusted earnings of $1.15​​ per share for the quarter ended December 31, identical to the same quarter last year. The mean expectation of six analysts for the quarter was for earnings of $1.13 per share. Wall Street expected results to range from 90 cents to $1.37 per share.

• Revenue rose 6.3% to $2.56 billion from a year ago; analysts expected $2.51 billion.

• The company reported quarterly net income of $93 million.

• Bausch Health Companies Inc shares had fallen by 10.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.4% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "hold"

Wall Street's median 12-month price target for Bausch Health Companies Inc is $8.50

This summary was machine generated from LSEG data February 21 at 12:48 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)